US FDA Grants XVIVO Approval to Include DCD Hearts in IDE Clinical Trial
GOTHENBURG, SWEDEN / ACCESSWIRE / July 25, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The US Food & Drug Administration (FDA)...
Month: July 2023
Medicure to Present Financial Results on July 31, 2023 Call at 8:30 AM ET for Quarter Ended June 30, 2023
WINNIPEG, MB / ACCESSWIRE / July 24, 2023 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused...
Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared...
NextGen Healthcare Reports Fiscal 2024 First Quarter Results
Raises Midpoint of Fiscal 2024 Revenue Guidance RangeREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of...
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
National Minority Quality Forum Urges Policymakers to Ensure Equitable Access to New Respiratory Syncytial Virus Immunizations
Health Equity Action Report shows low-income children of color are at high risk of severe RSVWashington, D.C.--(Newsfile Corp. - July...
Champions Oncology Reports Quarterly Revenue of $13.1 Million
Record Annual Revenue of $53.9 MillionHACKENSACK, NJ / ACCESSWIRE / July 24, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading...
CAN Community Health Names Terry Dyer as Director of Donor Development
Non-Profit Healthcare Organization Expands National Donor Engagement EffortsSARASOTA, FL / ACCESSWIRE / July 24, 2023 / Nationally renowned CAN Community...
Cloud DX Signs Record-Breaking 20th Contract, on Pace to Double Sales in 2023
News in SummaryWestern Canadian primary care group awards a new Remote Patient Monitoring (RPM) contract to Cloud DX after a...
Odyssey Unveils Rebrand of Eating Disorder Outpatient Clinics to Support Strategic Vision and Accelerated Growth
Continuing to provide a full spectrum of eating disorder treatment, four Selah House Outpatient clinics have rebranded as Aster Springs...
MDaudit Enhances Industry Leading Billing Compliance and Revenue Integrity Platform with Groundbreaking AI Capabilities
Insights.ai and SmartScan.ai optimize compliance and revenue integrity by unlocking access to deeper, more meaningful insights and automating key external...
Emagine Solutions Technology Wins $1 Million in R&D Funding from the U.S. National Science Foundation
Latest fundraising effort to strengthen Emagine’s powerful suite of maternal health toolsTUCSON, Ariz.--(BUSINESS WIRE)--Emagine Solutions Technology has been awarded $1...
LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups
Private equity-owned ophthalmology group, EyeSouth Partners, adopts ALLY for each operating room within its Gainesville, Georgia and Boynton Beach, Florida...
Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery
SAN FRANCISCO, CA / ACCESSWIRE / July 24, 2023 / A recent peer-reviewed study published in the American Journal of...
Health Karma Group Announces a Strategic Partnership with RocketTools.io AI-Drive Creative Services
FORT LAUDERDALE, FL / ACCESSWIRE / July 24, 2023 / MediXall Group Inc. (OTC PINK:MDXL) ("MediXall"), an innovative virtual health...
Vytalize Health Launches Charitable Initiative to Relieve Medical Debt Burden
Initial donation to RIP Medical Debt will erase $2 million in debt for families living on Long Island, furthering Vytalize...
Apellis Pharmaceuticals to Host Conference Call on July 31, 2023, to Discuss Second Quarter 2023 Financial Results
WALTHAM, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement,...
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical...
Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients
RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or...
Curia expands biologics capabilities with access to Touchlight’s doggybone DNA
Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to enzymatic doggybone DNA (dbDNA™)ALBANY, N.Y. and...